Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder

Bulletin Express

2025/12/04

Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.

Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1198166631"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198166631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198166631?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 19:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198166631","market":"hk","top_or_hot":-1,"title":"Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.</p>\n<p>Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Junshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJunshi Bio (HKEX: 1877, SSE: 688180) Announces Share Reduction Results of Major Shareholder\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-04 19:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.</p>\n<p>Following the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1198166631","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198166631","pubTimestamp":1764848749,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"君实生物（港交所：1877，上交所：688180）公布大股东减持股份结果","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd. disclosed that Shanghai Tanying Investment Partnership (LP), previously holding 71,459,326 A shares (6.9602% of total share capital), completed a shareholding reduction plan within the authorized timeframe from 5 September 2025 to 4 December 2025. According to the official announcement, Shanghai Tanying sold 12,000,000 A shares via block trading, representing approximately 1.1688% of the total share capital.\nFollowing the transaction, Shanghai Tanying now holds 59,459,326 A shares, which constitutes about 5.7914% of the total share capital. This shareholding reduction was prompted by fund maturity and liquidity arrangements, and aligned with disclosures previously made in August 2025. The plan’s execution has concluded, and no further reductions are indicated.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}